KUANO

GTN LTD. is reducing risks and accelerating drug development by combining quantum and artificial intelligence. A unique biotechnology platform utilizes flexible tools to address various drug design challenges. By collaborating with enzyme inhibitors in a distinctive way, continuous development of tools to tackle the challenges of using machine learning and quantum simulations in drug discovery is ongoing. This strategy significantly enhances the quality of new drug production and reduces discovery time.